Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H8Br4O10S2.2Na |
Molecular Weight | 837.997 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].OC(=O)C1=C(Br)C(Br)=C(Br)C(Br)=C1C(C2=CC=C(O)C(=C2)S([O-])(=O)=O)=C3C=CC(=O)C(=C3)S([O-])(=O)=O
InChI
InChIKey=HXUITPQMHVLBNV-LIYVDSPJSA-L
InChI=1S/C20H10Br4O10S2.2Na/c21-16-14(15(20(27)28)17(22)19(24)18(16)23)13(7-1-3-9(25)11(5-7)35(29,30)31)8-2-4-10(26)12(6-8)36(32,33)34;;/h1-6,25H,(H,27,28)(H,29,30,31)(H,32,33,34);;/q;2*+1/p-2/b13-8+;;
Sulfobromophthalein (BSP) is a dye with a high affinity for organic anion transporting polypeptides (OATPs) and has been used as a substrate for multidrug resistance associated protein 2 (Mrp2). BSP is transported into hepatocytes by OATPs and, after conjugation to glutathione, is excreted into bile by Mrp2.3 It was found to inhibit the aldo-keto reductase ARK1C20. Sulfobromophthalein (BSP) is used in diagnosis of hepatic disorders.It is also used for the quantitative determination of proteins.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14192521
Curator's Comment: Sulfobromophthalein sodium (BSP, Bromsulphalein) has been used extensively for testing hepatic function since its introduction by Rosenthal and White in 1925
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1697668 |
44.0 nM [Ki] | ||
Target ID: glutathione S-transferase, Oesophagostomum dentatum |
|||
Target ID: CHEMBL2073676 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15618649 |
2.18 µM [Ki] | ||
Target ID: 116852.0 Gene Symbol: Akr1c20 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16508162 |
1.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Bromosulfoftaleina Sodium Approved UseDiagnostic aid in hepatic function determination |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15618649
Rats: 350mg/day, i.v.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6019914
In competitive binding studies in vitro between
Sulfobromophthalein (BSP) and a series of organic anions
(sodium fluorescein, indocyanine green, bilirubin,
sodium taurocholate, flavaspidic acid
glucaminate, and iodipamide methylglucamine),
the incubation mixture contained 500 ug of BSP and equimolar amounts of the
aforementional organic anions. On the average,
160 +/- 2 ug BSP was bound per mg of membrane
protein and 1.4 +/-0.1 ug BSP bound
per unit of Co++-CMPase activity in 15
membrane isolates. BSP binding
was maximal at 500 ug BSP/ml in the
incubation mix with proportionately less binding
observed at lower concentrations. BSP
concentrations above 500 ug/ml reduced BSP
binding and produced dissolution of cell membranes.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
62E5JU30OV
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
1260372-63-1
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
ALTERNATIVE | |||
|
63827
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
C87725
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
200-761-0
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
71-67-0
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
Sulphobromophthalein
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
300000039633
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
CHEMBL574431
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
DTXSID9023621
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
2183
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
SUB15430MIG
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | |||
|
203200
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | RxNorm | ||
|
m10354
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY | Merck Index | ||
|
44134957
Created by
admin on Sat Dec 16 04:39:34 GMT 2023 , Edited by admin on Sat Dec 16 04:39:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD